Mankind Pharma’s success boosts hopes of more consumer IPOs in India

The strong performance of Mankind Pharma Ltd. in the stock market is expected to lead to more consumer-related initial public offerings (IPOs) in India. Mankind Pharma, known for its popular consumer products, raised $528 million in its IPO and has seen its shares rise by 57% in just two months. The success of the company has generated interest in India’s IPO market, which has raised nearly $2.1 billion this year. With a growing domestic consumption and favorable government policies, India is becoming an attractive market for investors.